<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Pharming Group NV (PHAR)</title>
    <description>Latest news, press releases, and SEC filings for Pharming Group NV (PHAR)</description>
    <link>https://caymanjournal.com/stock/PHAR</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 00:03:59 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/PHAR/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>6-K — Pharming Group N.V.</title>
      <description># 📄 What This Document Is

This is a **Form 6-K**, a special report that foreign companies (like this Dutch one) must file with the U.S. Securities and Exchange Commission (SEC) when they release important news to investors in their home country.

Think of it as an official &quot;news alert&quot; for America</description>
      <link>https://caymanjournal.com/stock/PHAR/sec-filing/0001828316-26-000017</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/PHAR/sec-filing/0001828316-26-000017</guid>
      <pubDate>Thu, 02 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>